Pages that link to "Q43199306"
Jump to navigation
Jump to search
The following pages link to High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis (Q43199306):
Displaying 50 items.
- Novel therapeutic targets for pancreatic cancer (Q24564267) (← links)
- Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinoma (Q26739910) (← links)
- Hedgehog Signaling in Pancreatic Fibrosis and Cancer (Q26766578) (← links)
- Role of histone deacetylases in pancreas: Implications for pathogenesis and therapy (Q26774080) (← links)
- NF-κB Expression and Outcomes in Solid Tumors: A Systematic Review and Meta-Analysis (Q26786151) (← links)
- Role of calcium, vitamin D, and the extrarenal vitamin D hydroxylases in carcinogenesis (Q27011538) (← links)
- Pristimerin causes G1 arrest, induces apoptosis, and enhances the chemosensitivity to gemcitabine in pancreatic cancer cells (Q28482913) (← links)
- High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo (Q30884835) (← links)
- Design, synthesis, and biological evaluation of novel EF24 and EF31 analogs as potential IκB kinase β inhibitors for the treatment of pancreatic cancer (Q33713919) (← links)
- Metadherin, p50, and p65 expression in epithelial ovarian neoplasms: an immunohistochemical study (Q33746151) (← links)
- α-Mangostin: a dietary antioxidant derived from the pericarp of Garcinia mangostana L. inhibits pancreatic tumor growth in xenograft mouse model (Q33924785) (← links)
- Rationale for possible targeting of histone deacetylase signaling in cancer diseases with a special reference to pancreatic cancer (Q34240470) (← links)
- miR-301a as an NF-κB activator in pancreatic cancer cells (Q34485753) (← links)
- PARP1 and phospho-p65 protein expression is increased in human HER2-positive breast cancers (Q35410911) (← links)
- Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells (Q35486194) (← links)
- Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer (Q35576601) (← links)
- Comprehensive Evaluation of Nuclear Factor-κΒ Expression Patterns in Non-Small Cell Lung Cancer. (Q35683345) (← links)
- Expression of nuclear transcription factor kappa B in locally advanced human cervical cancer treated with definitive chemoradiation (Q35770197) (← links)
- Chronic inflammation in cancer development. (Q35928265) (← links)
- Da0324, an inhibitor of nuclear factor-κB activation, demonstrates selective antitumor activity on human gastric cancer cells (Q35978864) (← links)
- Nuclear factor-κB expression is predictive of overall survival in patients with cutaneous melanoma. (Q36217015) (← links)
- Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy (Q36778047) (← links)
- Apoptotic pathways in pancreatic ductal adenocarcinoma (Q36835642) (← links)
- NF-kappaB and cancer-identifying targets and mechanisms (Q36984251) (← links)
- Mucin glycosylating enzyme GALNT2 suppresses malignancy in gastric adenocarcinoma by reducing MET phosphorylation (Q36998213) (← links)
- Deep sequencing and in silico analyses identify MYB-regulated gene networks and signaling pathways in pancreatic cancer (Q37049673) (← links)
- Inflammation and cancer: how friendly is the relationship for cancer patients? (Q37316105) (← links)
- Cell survival and apoptosis-related molecules in cancer cells in effusions: a comprehensive review (Q37471658) (← links)
- Consensus on the treatment of pancreatic cancer in Spain. (Q37487167) (← links)
- Overexpression of G protein-coupled receptor GPR87 promotes pancreatic cancer aggressiveness and activates NF-κB signaling pathway (Q37697856) (← links)
- NFKB1 -94insertion/deletion ATTG polymorphism and cancer risk: Evidence from 50 case-control studies (Q37706069) (← links)
- Tissue Biomarkers for Prognosis in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis (Q37858851) (← links)
- NF-κB as a target for pancreatic cancer therapy. (Q37996435) (← links)
- Developing histone deacetylase inhibitors in the therapeutic armamentarium of pancreatic adenocarcinoma. (Q38012499) (← links)
- Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy. (Q38103859) (← links)
- Therapeutic microRNAs targeting the NF-kappa B signaling circuits of cancers (Q38249091) (← links)
- HDAC inhibitors, MS-275 and salermide, potentiates the anticancer effect of EF24 in human pancreatic cancer cells (Q38762886) (← links)
- W346 inhibits cell growth, invasion, induces cycle arrest and potentiates apoptosis in human gastric cancer cells in vitro through the NF-κB signaling pathway. (Q38823195) (← links)
- TRAF6 is over-expressed in pancreatic cancer and promotes the tumorigenicity of pancreatic cancer cells (Q38953657) (← links)
- Nuclear factor κB activity correlates with the progression and prognosis of pancreatic cancer in a mouse model (Q39297500) (← links)
- Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma. (Q39323428) (← links)
- The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC) (Q39502331) (← links)
- Co-expression of β-arrestin1 and NF-кB is associated with cancer progression and poor prognosis in lung adenocarcinoma (Q41143599) (← links)
- Gemcitabine-induced heparanase promotes aggressiveness of pancreatic cancer cells via activating EGFR signaling. (Q41709484) (← links)
- A 25-gene classifier predicts overall survival in resectable pancreatic cancer (Q41711884) (← links)
- Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer (Q41841905) (← links)
- Inflammation and cancer (Q41853728) (← links)
- The effect of specific IKKβ inhibitors on the cytosolic expression of IκB-α and the nuclear expression of p65 in dystrophic (MDX) muscle (Q41888348) (← links)
- Association Between NFKB1 -94ins/delATTG Promoter Polymorphism and Cancer Risk: A Meta-Analysis (Q43535631) (← links)
- NF-kappaB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK/T-cell lymphoma, nasal type. (Q46036136) (← links)